1. Home
  2. CABO vs BEAM Comparison

CABO vs BEAM Comparison

Compare CABO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

N/A

Current Price

$136.25

Market Cap

603.1M

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$27.53

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CABO
BEAM
Founded
1980
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
603.1M
2.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CABO
BEAM
Price
$136.25
$27.53
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
$126.00
$48.09
AVG Volume (30 Days)
146.6K
2.0M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
2.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,524,897,000.00
$55,701,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$96.67
$13.53
52 Week High
$400.62
$35.25

Technical Indicators

Market Signals
Indicator
CABO
BEAM
Relative Strength Index (RSI) 57.87 61.30
Support Level $119.44 $25.86
Resistance Level $128.95 $28.28
Average True Range (ATR) 6.41 1.58
MACD 3.83 0.40
Stochastic Oscillator 92.30 81.84

Price Performance

Historical Comparison
CABO
BEAM

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: